21-hydroxylase deficiency differential diagnosis: Difference between revisions
Aditya Ganti (talk | contribs) |
|||
(52 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/21-hydroxylase_deficiency]] | |||
{{CMG}} {{AE}} {{ | {{CMG}}; {{AE}} {{MJ}} | ||
==Overview== | ==Overview== | ||
21-hydroxylase deficiency must be differentiated from [[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency|11-β hydroxylase deficiency]], [[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency|17-α hydroxylase deficiency]], [[androgen insensitivity syndrome]], [[3 beta-hydroxysteroid dehydrogenase deficiency|3 beta-hydroxysteroid dehydrogenase deficiency]], [[polycystic ovarian syndrome]], [[hyperprolactinemia]], [[cushing syndrome]], and [[adrenal tumor]]. | |||
==Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases== | ==Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases== | ||
[[Congenital adrenal hyperplasia]] due to 21-hydroxylase deficiency must be differentiated from | 21-hydroxylase deficiency classic form should be differentiated from other diseases that cause [[ambiguous genitalia]], and non-classic form should be differentiated from the diseases that cause female [[hirsutism]]. | ||
*[[ | |||
*11-β hydroxylase deficiency | '''21-hydroxylase deficiency classic type must be differentiated from diseases that cause [[ambiguous genitalia]]:'''<ref name="pmid17875484">{{cite journal |vauthors=Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT |title=Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development |journal=Best Pract. Res. Clin. Endocrinol. Metab. |volume=21 |issue=3 |pages=351–65 |year=2007 |pmid=17875484 |doi=10.1016/j.beem.2007.06.003 |url=}}</ref><ref name="pmid10857554">{{cite journal |vauthors=White PC, Speiser PW |title=Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |journal=Endocr. Rev. |volume=21 |issue=3 |pages=245–91 |year=2000 |pmid=10857554 |doi=10.1210/edrv.21.3.0398 |url=}}</ref> | ||
*17- | {| class="wikitable" | ||
*[[Polycystic Ovarian | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name | ||
*[[ | ! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Steroid status | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Important clinical findings | |||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Increased | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Decreased | |||
|- | |||
| align="center" style="background:#DCDCDC; + |[[21-hydroxylase deficiency|Classic type of 21-hydroxylase deficiency]] | |||
| | |||
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | |||
* [[Progesterone]] | |||
* [[Androstenedione]] | |||
* [[DHEA]] | |||
| | |||
* [[Aldosterone]] | |||
* [[Corticosterone]] (salt-wasting) | |||
* [[Cortisol]] | |||
| | |||
* [[Ambiguous genitalia]] in female | |||
* [[Virilization]] in female | |||
* Salt-wasting | |||
* [[Hypotension]] and [[hyperkalemia]] | |||
|- | |||
| align="center" style="background:#DCDCDC; + |[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | |||
| | |||
* [[Deoxycorticosterone]] | |||
* 11-Deoxy-[[cortisol]] | |||
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] (mild elevation) | |||
| | |||
* [[Cortisol]] | |||
* [[Corticosterone]] | |||
* [[Aldosterone]] | |||
| | |||
* [[Ambiguous genitalia]] in female | |||
* [[Hypertension]] and [[hypokalemia]] | |||
* [[Virilization]] | |||
|- | |||
| align="center" style="background:#DCDCDC; + |[[17 alpha-hydroxylase deficiency|17-α hydroxylase deficiency]] | |||
| | |||
* [[Deoxycorticosterone]] | |||
* [[Corticosterone]] | |||
* [[Progesterone]] | |||
| | |||
* [[Cortisol]] | |||
* [[Aldosterone]] | |||
| | |||
* [[Ambiguous genitalia]] in male | |||
* [[Hypertension]] | |||
* [[Primary amenorrhea]] | |||
* Absence of [[secondary sexual characteristics]] | |||
* Minimal [[body hair]] | |||
|- | |||
| align="center" style="background:#DCDCDC; + |[[3 beta-hydroxysteroid dehydrogenase deficiency]] | |||
| | |||
* [[Dehydroepiandrosterone]] | |||
* [[17-hydroxypregnenolone]] | |||
* [[Pregnenolone]] | |||
| | |||
* [[Cortisol]] | |||
* [[Aldosterone]] | |||
| | |||
* [[Vomiting]], [[volume depletion]], [[hyponatremia]], and [[hyperkalemia]] | |||
* 46-XY infants often show [[undervirilization]], due to a block in [[testosterone]] synthesis | |||
|- | |||
| align="center" style="background:#DCDCDC; + |Gestational [[hyperandrogenism]] | |||
| colspan="2" | | |||
* Maternal serum [[androgen]] concentrations (usually [[testosterone]] and [[androstenedione]]) are high | |||
* If [[virilization]] is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic [[steroid]] not measured in assays for [[testosterone]] or other [[androgens]] | |||
| | |||
* [[Androgen]] excess in mother | |||
* History of [[androgen]] containing [[medication]] consumption during [[pregnancy]] in mother | |||
* [[Virilization]] in a 46,XX individual with normal female internal anatomy | |||
* Causes include maternal [[luteoma]] or theca-[[lutein]] [[cysts]], and [[placental]] [[aromatase]] enzyme deficiency | |||
|} | |||
'''[[21-hydroxylase deficiency]] non-classic type must be differentiated from diseases that cause [[virilization]] and [[hirsutism]] in female:'''<ref name="pmid10857554">{{cite journal |vauthors=White PC, Speiser PW |title=Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |journal=Endocr. Rev. |volume=21 |issue=3 |pages=245–91 |year=2000 |pmid=10857554 |doi=10.1210/edrv.21.3.0398 |url=}}</ref><ref name="pmid24830586">{{cite journal| author=Hohl A, Ronsoni MF, Oliveira Md| title=Hirsutism: diagnosis and treatment. | journal=Arq Bras Endocrinol Metabol | year= 2014 | volume= 58 | issue= 2 | pages= 97-107 | pmid=24830586 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24830586 }} </ref><ref name="ISBN:978-0323297387">{{cite book | last = Melmed | first = Shlomo | title = Williams textbook of endocrinology | publisher = Elsevier | location = Philadelphia, PA | year = 2016 | isbn = 978-0323297387 }}=</ref> | |||
{| class="wikitable" | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Steroid status | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other laboratory | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Important clinical findings | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |Non-classic type of [[21-hydroxylase deficiency]] | |||
|Increased: | |||
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | |||
* Exaggerated [[Androstenedione]], [[DHEA]], and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] in response to [[ACTH]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* No symptoms in infancy and male | |||
* [[Virilization]] in females | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | |||
|Increased: | |||
* DOC | |||
* 11-Deoxy-[[Cortisol]] | |||
Decreased: | |||
* [[Cortisol]] | |||
* [[Corticosterone]] | |||
* [[Aldosterone]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* [[Hypertension]] and [[hypokalemia]] | |||
* [[Virilization]] | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |[[3 beta-hydroxysteroid dehydrogenase deficiency]] | |||
|Increased: | |||
* [[DHEA]] | |||
* [[17-hydroxypregnenolone]] | |||
* [[Pregnenolone]] | |||
Decreased: | |||
* [[Cortisol]] | |||
* [[Aldosterone]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* Salt-wasting [[adrenal crisis]] in infancy | |||
* Mild [[virilization]] of genetically female infants | |||
* [[Undervirilization]] of genetically male infants, making it the only form of [[CAH]] which can cause [[ambiguous genitalia]] in both genetic sexes. | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |[[Polycystic ovary syndrome ]] | |||
| | |||
* High [[DHEAS]] and [[androstenedione]] levels | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* [[Polycystic ovaries]] in sonography | |||
* [[Obesity]] | |||
* [[PCOS]] is the most common cause of [[hirsutism]] in women | |||
* No evidence another diagnosis | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |[[Adrenal tumors]] | |||
| | |||
* Variable levels depends on [[tumor]] type | |||
| | |||
* Low [[testosterone]] level | |||
| | |||
* Older age | |||
* Rapidly progressive symptoms | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |Ovarian [[virilizing]] tumor | |||
| | |||
* Variable levels depends on [[tumor]] type | |||
| | |||
* [[Testosterone]] is high | |||
| | |||
* Older age | |||
* Rapidly progressive symptoms | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |[[Cushing's syndrome]] | |||
| | |||
* Increase [[cortisol]] & metabolites | |||
* Variable other [[steroids]] | |||
| | |||
* Variable [[mineralocorticoid]] excess | |||
| | |||
* [[Cushingoid appearance]] | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |[[Hyperprolactinemia]] | |||
| | |||
* Normal levels of most of [[steroids]] | |||
| | |||
* Increased [[prolactin]] | |||
| | |||
* [[Infertility]], [[galactorrhea]] | |||
|} | |||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{ | {{WH}} | ||
{{ | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
Line 23: | Line 195: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Intersexuality]] | [[Category:Intersexuality]] | ||
[[Category:Medicine]] | |||
[[Category: Up-To-Date]] |
Latest revision as of 15:38, 24 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
21-hydroxylase deficiency must be differentiated from 11-β hydroxylase deficiency, 17-α hydroxylase deficiency, androgen insensitivity syndrome, 3 beta-hydroxysteroid dehydrogenase deficiency, polycystic ovarian syndrome, hyperprolactinemia, cushing syndrome, and adrenal tumor.
Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases
21-hydroxylase deficiency classic form should be differentiated from other diseases that cause ambiguous genitalia, and non-classic form should be differentiated from the diseases that cause female hirsutism.
21-hydroxylase deficiency classic type must be differentiated from diseases that cause ambiguous genitalia:[1][2]
Disease name | Steroid status | Important clinical findings | |
---|---|---|---|
Increased | Decreased | ||
Classic type of 21-hydroxylase deficiency |
|
| |
11-β hydroxylase deficiency |
|
| |
17-α hydroxylase deficiency |
| ||
3 beta-hydroxysteroid dehydrogenase deficiency |
| ||
Gestational hyperandrogenism |
|
|
21-hydroxylase deficiency non-classic type must be differentiated from diseases that cause virilization and hirsutism in female:[2][3][4]
Disease name | Steroid status | Other laboratory | Important clinical findings |
---|---|---|---|
Non-classic type of 21-hydroxylase deficiency | Increased:
|
|
|
11-β hydroxylase deficiency | Increased:
Decreased: |
|
|
3 beta-hydroxysteroid dehydrogenase deficiency | Increased:
Decreased: |
|
|
Polycystic ovary syndrome |
|
|
|
Adrenal tumors |
|
|
|
Ovarian virilizing tumor |
|
|
|
Cushing's syndrome |
|
||
Hyperprolactinemia |
|
|
References
- ↑ Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT (2007). "Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development". Best Pract. Res. Clin. Endocrinol. Metab. 21 (3): 351–65. doi:10.1016/j.beem.2007.06.003. PMID 17875484.
- ↑ 2.0 2.1 White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.
- ↑ Hohl A, Ronsoni MF, Oliveira Md (2014). "Hirsutism: diagnosis and treatment". Arq Bras Endocrinol Metabol. 58 (2): 97–107. PMID 24830586.
- ↑ Melmed, Shlomo (2016). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 978-0323297387.=